Lluis Puig

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 362 publications

Pinch grafting in combination with microperforations on the ulcer bed: an optimal symbiosis for the treatment of hard-to-heal ulcers: a case series.

Pinch grafting in combination with microperforations on the ulcer bed: an optimal symbiosis for the treatment of hard-to-heal ulcers: a case series.

Journal: Journal of wound care

Published: August 10, 2026

Clinical features and survival analysis of cutaneous metastases from visceral cancers: A multicenter retrospective study.

Clinical features and survival analysis of cutaneous metastases from visceral cancers: A multicenter retrospective study.

Journal: JAAD international

Published: June 08, 2026

Antimicrobial prophylaxis regimens in joint replacement surgery: susceptibility and PK/PD target attainment.

Antimicrobial prophylaxis regimens in joint replacement surgery: susceptibility and PK/PD target attainment.

Journal: International journal of antimicrobial agents

Published: March 31, 2026

Real-World Evidence That As-Needed Dosing with Bimekizumab in Patients with Psoriasis Is Safe and Effective over Time.

Real-World Evidence That As-Needed Dosing with Bimekizumab in Patients with Psoriasis Is Safe and Effective over Time.

Journal: Journal of personalized medicine

Published: March 25, 2026

Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials.

Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials.

Journal: American journal of clinical dermatology

Published: January 15, 2026

Targeted therapies for psoriasis and atopic dermatitis in the context of malignancy: SPIN-FRT recommendations.

Targeted therapies for psoriasis and atopic dermatitis in the context of malignancy: SPIN-FRT recommendations.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 14, 2025

Updated guidelines on hepatitis B virus infection management in patients treated with systemic immunomodulatory agents.

Updated guidelines on hepatitis B virus infection management in patients treated with systemic immunomodulatory agents.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 19, 2025

Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison.

Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison.

Journal: Dermatology and therapy

Published: September 24, 2025

Should TNF inhibitors be avoided in psoriasis patients with latent tuberculosis?

Should TNF inhibitors be avoided in psoriasis patients with latent tuberculosis?

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: September 12, 2025

Comparison of All-Cause Mortality in Generalized Pustular Psoriasis and Plaque Psoriasis: A Systematic Review and Meta-Analysis.

Comparison of All-Cause Mortality in Generalized Pustular Psoriasis and Plaque Psoriasis: A Systematic Review and Meta-Analysis.

Journal: Dermatology and therapy

Published: September 01, 2025

Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors.

Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors.

Journal: Journal of the American Academy of Dermatology

Published: August 24, 2025

Predictors of response to omalizumab and relapse in chronic spontaneous Urticaria: a narrative review focusing on parameters available in routine clinical practice.

Predictors of response to omalizumab and relapse in chronic spontaneous Urticaria: a narrative review focusing on parameters available in routine clinical practice.

Journal: Frontiers in allergy

Published: August 19, 2025

Showing 1-12 of 362

Last Updated: 09/26/2026